ESSA Pharma Inc.: IND 1Q2020. Developing small molecule drugs for the treatment of CRPC. Lead asset selectively blocks the n-terminal domain of the androgen receptor, potentially overcoming the known AR-dependent resistance mechanisms of CRPC and providing CRPC patients with the potential for increased progression-free and overall survival. Preclincial data packet shows a favorable PK profile + exhibits significant exposure potential with a long half-life. Cash into 2023.
Based in...
North America
Disease Space
Public, USA
Market Cap
100MM - 500MM
999 West Broadway Street Suite 720
Vancouver, British Columbia BC V5Z 1K5

Send Message to Request Information

Log in to download presentation, request a 1x1 meeting, view additional roadshows, and more.

Top 10 Holders of ESSA Pharma Inc

Institution OS (%) Position Mkt Val ($MM) Source Filing Date
BVF Partners LP 53.94 3,403,998 21.10 Stakes 2020-01-22
Soleus Capital Management LP (Investment Management) 53.45 3,373,054 20.91 Stakes 2020-01-22
Clarus Ventures LLC 53.45 3,373,053 20.91 13F 2020-03-31
BVF, Inc. 38.35 2,420,565 15.01 13F 2020-03-31
Soleus Capital Management LP 32.96 2,080,421 12.90 13F 2020-03-31
Eventide Asset Management LLC 31.85 2,010,169 12.46 13F 2020-03-31
Omega Fund Management LLC 26.78 1,689,848 10.48 13F 2020-03-31
OrbiMed Advisors LLC 23.32 1,471,853 9.13 13F 2020-03-31
RA Capital Management LLC 15.20 959,300 5.95 13F 2020-03-31
Janus Capital Management LLC 3.15 198,799 1.23 13F 2020-03-31
Ownership data is sourced through FactSet.

Stock Market Data

Data is being loaded...
Data is being loaded...
Data is being loaded...
Data is being loaded...
Market Data copyright © 2020 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, RTB=Real-Time BATS BZX Price/Quote; not sourced from all markets, RTN=Real-Time NASDAQ Basic+ Price/Quote; not sourced from all markets, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.